This trial is !
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Solid Tumor
and you are
over 18
years old
Phase
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

The purpose of this study is to determine whether haNK™ for Infusion is safe and effective in the treatment of metastatic or locally advanced solid tumors.

Provided treatments

  • Biological: haNK™ for Infusion
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03027128. The sponsor of the trial is NantKwest, Inc. and it is looking for 16 volunteers for the current phase.
Official trial title:
Open-label, Phase 1 Study of haNK™ for Infusion in Subjects With Metastatic or Locally Advanced Solid Tumors